Diabetes mellitus increases the risk of developing heart failure, and the co-existence of both
diseases worsens cardiovascular outcomes, hospitalization, and the progression of heart …

Diabetic cardiomyopathy (DbCM) is a common complication in individuals with type 2
diabetes mellitus (T2DM), and its exact pathogenesis is still debated. It was hypothesized …

Trastuzumab (Trz) is a humanized monoclonal antibody targeting epidermal growth factor
receptor 2 (HER2; ErbB2). The combined administration of Trz and doxorubicin (DOX) has …

Aluminum phosphide (AlP) causes serious poisoning in which severe cardiac suppression
is the significant lethal consequence. According to evidence, levosimendan can exert …

ABSTRACT Background: Sacubitril (SAC), a neprilysin inhibitor prevent degradation of
neprilysin and activate cGMP signaling pathways leading to rise in blood volume concurrent …

Background: Doxorubicin (DOX) is a potential chemotherapeutic agent but its use is
restricted due to cardiotoxicity. Edaravone is a potent-free radical scavenging agent used in …

Background We hypothesized that consumption of Vitis vinifera seed by diabetics could help
to ameliorate myocardial damage. Therefore, in this study, we investigated effects of V …

New Findings What is the central question of this study? Type 2 diabetes is associated with
a higher rate of ventricular arrhythmias compared with the non‐diabetic population, but the …

Type 2 diabetes (T2D) is a multisystem disease with rapidly increasing global prevalence.
Heart failure has emerged as a major complication of T2D. Dysregulated myocardial calcium …

Inotropic agents are generally recommended to use in patients with acute decompensated
heart failure (HF) with reduced ejection fraction (HFrEF) concurrent to end-organ …